Department of Genetics, Blavatnik Institute, Harvard Medical School, 77 Avenue Louis Pasteur, NRB 336, Boston, MA, 02115, United States; Aging Institute of UPMC and the University of Pittsburgh, Pittsburgh, PA, United States.
Department of Genetics, Blavatnik Institute, Harvard Medical School, 77 Avenue Louis Pasteur, NRB 336, Boston, MA, 02115, United States.
Ageing Res Rev. 2020 Dec;64:101188. doi: 10.1016/j.arr.2020.101188. Epub 2020 Oct 5.
Metabolism plays a significant role in the regulation of aging at different levels, and metabolic reprogramming represents a major driving force in aging. Metabolic reprogramming leads to impaired organismal fitness, an age-dependent increase in susceptibility to diseases, decreased ability to mount a stress response, and increased frailty. The complexity of age-dependent metabolic reprogramming comes from the multitude of levels on which metabolic changes can be connected to aging and regulation of lifespan. This is further complicated by the different metabolic requirements of various tissues, cross-organ communication via metabolite secretion, and direct effects of metabolites on epigenetic state and redox regulation; however, not all of these changes are causative to aging. Studies in yeast, flies, worms, and mice have played a crucial role in identifying mechanistic links between observed changes in various metabolic traits and their effects on lifespan. Here, we review how changes in the organismal and organ-specific metabolome are associated with aging and how targeting of any one of over a hundred different targets in specific metabolic pathways can extend lifespan. An important corollary is that restriction or supplementation of different metabolites can change activity of these metabolic pathways in ways that improve healthspan and extend lifespan in different organisms. Due to the high levels of conservation of metabolism in general, translating findings from model systems to human beings will allow for the development of effective strategies for human health- and lifespan extension.
新陈代谢在不同层面上对衰老的调节起着重要作用,而代谢重编程是衰老的主要驱动力之一。代谢重编程导致机体适应性下降,患病易感性随年龄增长而增加,应激反应能力下降,脆弱性增加。与衰老和寿命调节相关的代谢变化可以在多个层面上发生,这使得年龄依赖性代谢重编程的复杂性增加。此外,不同组织的不同代谢需求、通过代谢物分泌进行的器官间通讯以及代谢物对表观遗传状态和氧化还原调节的直接影响,进一步增加了这种复杂性;然而,并非所有这些变化都与衰老有关。在酵母、果蝇、线虫和小鼠中的研究在确定观察到的各种代谢特征变化与寿命之间的机制联系方面发挥了关键作用。在这里,我们综述了机体和器官特异性代谢组的变化如何与衰老相关,以及靶向特定代谢途径中超过 100 个不同靶点中的任何一个如何延长寿命。一个重要的推论是,不同代谢物的限制或补充可以改变这些代谢途径的活性,从而以改善不同生物体的健康寿命和延长寿命的方式发挥作用。由于新陈代谢在一般意义上具有高度的保守性,将模型系统中的发现转化为人类,将为人类健康和寿命延长制定有效的策略。